Jump to any asset
850 assets, updated daily
As of September 13, 2026, Stryker Corp. (SYK) trades at $275.56. CleaRank Financial AI rates it Buy with a fair value of $380.00, 37.9% above the current price. Wall Street's consensus target is $380.00 across 28 analysts. RSI at 19 is in oversold territory, and the price is below its 50-day average of $325.03.
Stryker Corp. (SYK)
Stryker Corp. NYSE
$275.56
5.550 (2.06%)
At close: Sep 11, 4:00 PM EDT
AI Analyst Consensus
76 / 100
Stryker Corp. (SYK) is currently trading at $275.56, significantly below its 50-day and 200-day moving averages ($325.03 and $336.68), indicating a bearish technical trend. However, the company's fundamentals remain strong, with a profit margin of 14.43% and a return on equity of 16.51%. Wall Street analysts maintain a 'Buy' consensus with a median price target of $380, suggesting a substantial 37.9% upside potential from current levels. The company is expected to achieve revenue growth of 10.00% in the current quarter and 12.00% in the next quarter, underscoring its growth trajectory within the medical devices sector.
SYK Price Analysis
Market Metrics
Open
$270.72
Day Range
$267.00 to $277.00
Prev Close
$270.01
Volume
3.72M
52-Week Range
$267.00 to $396.86
Market Cap
$105.70B
Peer Benchmarking
Valuation vs Sector (Healthcare)
Performance vs XLV
Sector Position Analysis
Valuation is broadly in line with sector peers (-10% difference), suggesting fair market pricing relative to industry standards.
SYK Financial Performance
Revenue vs. Earnings
Annual
Quarterly
Earnings Reality Check
Analysis: In the last 4 quarters, SYK beat estimates 3 times. However, the stock fell 2 times the next day. This suggests positive news is often "priced in" or investors are selling the news.
SYK Analysis
Company's Health
4/5
12-Month Analyst Target
+37.90% Upside
Median of 28 analysts (12-month)
$380.00
AI Technical Analysis
Stryker Corp. (SYK) exhibits significantly oversold technical conditions, with its RSI at 19.27, signaling a potential for a near-term bounce. The stock is trading below its 20-day, 50-day, and 200-day moving averages, with the 50-day SMA at $325.03 and the 200-day SMA at $336.68, indicating a strong downtrend. MACD is also negative at -14.35, reinforcing the bearish momentum. Volume on the latest trading day was 3.72 million, 14% above the average, suggesting increased selling pressure or potential accumulation at lower levels. Key support levels are not clearly defined due to the current trend, but the oversold RSI may offer a temporary floor.
ProTips
- Significant insider selling totaling over $738 million warrants close monitoring for any further negative signals.
- The current oversold RSI of 19.27 suggests a potential for a short-term technical bounce, offering a possible entry point for traders.
- Given the current bearish technical trend, consider implementing a stop-loss order below key support levels to manage downside risk.
Key Catalysts
Bullish
Strong Revenue Growth Projections
Analyst estimates indicate strong revenue growth of 10.00% for the current quarter and 12.00% for the next quarter, signaling continued market demand for Stryker's products.
Source: Wall Street EstimatesBullish
Oversold Technical Conditions
The RSI reading of 19.27 suggests the stock is significantly oversold, which historically precedes potential price reversals and could lead to a short-term rally.
Source: Technical AnalysisBearish
Heavy Insider Selling Activity
Over $738 million in insider sales have been recorded, indicating a potential lack of confidence from management and executives regarding the stock's near-term prospects.
Source: Insider TransactionsBearish
Bearish Moving Average Crossovers
Stryker Corp. is trading significantly below its 50-day and 200-day moving averages ($325.03 and $336.68), confirming a strong bearish trend and suggesting further downside potential.
Source: Technical AnalysisMarket Outlook
Stryker Corp. (SYK) is positioned for a potential recovery, with Wall Street analysts projecting a median price target of $380, implying a 37.9% upside from the current $275.56. The company's strong fundamental performance, including strong profit margins and projected revenue growth, supports this optimistic outlook. The current oversold RSI reading of 19.27 suggests that the stock may be due for a technical rebound. The company's forward-looking revenue growth estimates of 10.00% for the current quarter and 12.00% for the next quarter further strengthen the case for a positive trajectory.
Key Statistics
| Market Cap | 105.70B |
|---|---|
| P/E Ratio | 28.59 |
| EPS (TTM) | 9.64 |
| Dividend Yield | 1.26% |
| 52 Week High | 396.86 |
| 52 Week Low | 267.00 |
Stryker Corp. (SYK) trades at a P/E ratio of 28.59, which is slightly below the sector median of 31.9, suggesting a reasonable valuation relative to peers. Its price-to-sales ratio stands at 4.09, compared to the sector median of 3.7, indicating a slight premium. The company boasts a healthy profit margin of 14.43% and an operating margin of 27.02%, outperforming the sector's median ROE of 6.9%. With a debt-to-equity ratio of 0.64, the balance sheet appears manageable. Despite the current price weakness, the company's profitability and efficiency metrics suggest underlying strength.
Earnings & Growth Analysis
Stryker Corp. (SYK) recently reported Q2 2026 earnings with an EPS of $3.69, beating the estimate of $3.49 by 5.73%, though the stock reacted negatively with a -6.42% price change. This follows a pattern of mixed earnings performance, with a miss in the prior quarter (-12.75% surprise) and a beat in the quarter before that (+1.59% surprise). Revenue growth is projected to be strong, with an estimated 10.00% increase for the current quarter and 12.00% for the next quarter, indicating continued top-line expansion.
Key Risks
The primary risk for Stryker Corp. (SYK) stems from significant insider selling, with over $738 million in sales reported, indicating potential concerns among management regarding future performance or valuation. Additionally, the stock is trading significantly below its key moving averages, highlighting a strong bearish technical trend that could persist. While the company has a solid financial foundation, the heavy insider selling warrants caution and suggests potential headwinds not fully captured by current analyst targets.
Technical Indicators
| RSI (14) | 19.27 |
|---|---|
| MACD | -14.35 |
| SMA 50 | 325.03 |
| SMA 200 | 336.68 |
RSI
Oversold
SMA Cross
Bearish
Price vs SMA
Bearish
MACD
Bearish
Moving averages show a lagging Death Cross (50-day: $325.03, 200-day: $336.68), price is trading below the 50-day SMA, RSI at 19.3 suggests oversold conditions; potential bounce setup.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.36
Weak correlation
Nasdaq 100 (QQQ)
+0.21
Weak correlation
Bitcoin (BTC)
-0.17
Weak correlation
Gold (XAU)
+0.01
Weak correlation
Check Custom Correlation
Calculating correlation...
SYK Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
🟢 LONG ENTRY (click to switch)
CONSERVATIVE
$270.05
2% below current price (Pullback entry)
Lower risk, wait for pullback
AGGRESSIVE
$275.56
Buy at current price
Higher risk, immediate entry
Risk Management
STOP LOSS
$253.36
MAX LOSS
-6.2%
Volatility-Adjusted Stop Loss
Calculated based on RSI (19.3) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$283.55
+5% (Conservative)
+2.9% (Aggressive)
TARGET 2
$297.05
+10% (Conservative)
+7.8% (Aggressive)
TARGET 3
$310.56
+15% (Conservative)
+12.7% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
Disclaimer
This AI-generated trade plan for SYK is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on September 13, 2026.Growth of $10,000
A $10,000 investment in SYK in September 2016 would be worth about $24,933 today, compared with about $35,843 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in SYK today could grow to about $22,407 by 2036 in the base case, with a bull case near $67,056 and a bear case around $7,487. Projections are statistical simulations, not guarantees.
SYK Stock Price Prediction: 2030
CleaRank's simulation projects a price near $381 for SYK by 2030 in the base case, from $276 today (1.4x over 4 years). The downside path ends near $190. These are outcomes of a Monte Carlo simulation run on SYK's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $211 | $299 | $422 |
| 2028 | $198 | $324 | $529 |
| 2029 | $193 | $351 | $640 |
| 2030 | $190 | $381 | $761 |
| 2031 | $190 | $412 | $895 |
| 2032 | $191 | $447 | $1,045 |
| 2033 | $194 | $485 | $1,213 |
| 2034 | $197 | $525 | $1,401 |
| 2035 | $201 | $570 | $1,611 |
| 2036 | $206 | $617 | $1,848 |
Method: 10,000 simulated price paths using SYK's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
SYK Insider Trading Analysis
Bought
None
No open-market buys
Sold
$738.2M
16 Transactions
Insiders
22
Active Traders
Avg Transaction
$46.1M
Large trades
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Nov 6, 2025 | STRYKER RONDA E
Director
|
Sell | 520.0K | $184.6M |
| Feb 5, 2026 | STRYKER RONDA E
Director
|
Sell | 500.0K | $181.7M |
| Feb 7, 2023 | STRYKER RONDA E
Director and Beneficial Owner of more than 10% of a Class of Security
|
Sell | 520.0K | $141.9M |
| Aug 19, 2026 | STRYKER RONDA E
Director
|
Sell | 350.0K | $117.8M |
| Feb 6, 2024 | STRYKER RONDA E
Director and Beneficial Owner of more than 10% of a Class of Security
|
Sell | 293.4K | $100.3M |
| May 26, 2026 | STRYKER RONDA E
Director
|
Sell | 310.0K | $96.8M |
| Jan 31, 2025 | STRYKER RONDA E
Director and Beneficial Owner of more than 10% of a Class of Security
|
Sell | 236.0K | $92.7M |
| Nov 5, 2024 | STRYKER RONDA E
Director and Beneficial Owner of more than 10% of a Class of Security
|
Sell | 230.0K | $84.5M |
| Jan 31, 2025 | STRYKER RONDA E
Director and Beneficial Owner of more than 10% of a Class of Security
|
Sell | 201.4K | $79.0M |
| May 6, 2025 | STRYKER RONDA E
Director and Beneficial Owner of more than 10% of a Class of Security
|
Sell | 200.0K | $75.4M |
Page 1 of 1
Frequently Asked Questions
Is Stryker Corp. stock a buy right now?
Stryker Corp. (SYK) is currently rated a 'Buy' by Wall Street analysts, with a median price target of $380, offering a 37.9% upside from its current price of $275.56. The stock exhibits oversold technical conditions, which could precede a rebound, but significant insider selling presents a notable risk.
What is Stryker Corp.'s price target for September 2026?
The median analyst price target for Stryker Corp. (SYK) is $380, with a high of $465 and a low of $315. This target suggests an upside potential of 37.9% from the current price of $275.56.
How are Stryker Corp.'s recent earnings?
Stryker Corp. (SYK) most recently reported Q2 2026 EPS of $3.69, beating estimates by 5.73%, although the stock saw a negative price reaction. The company has a history of mixed earnings surprises but is expected to show strong revenue growth in the upcoming quarters.
What is the revenue growth outlook for Stryker Corp.?
Stryker Corp. (SYK) is projected to achieve revenue growth of 10.00% in the current quarter and 12.00% in the next quarter. For the full year, revenue growth is estimated at 9.00%, with a similar projection for the following year.
What are the main risks facing Stryker Corp.?
The primary risks for Stryker Corp. (SYK) include significant insider selling totaling over $738 million, which may signal management concerns, and a prevailing bearish technical trend with the stock trading well below its key moving averages.
How does Stryker Corp. compare to its sector peers?
Stryker Corp. (SYK) operates in the Healthcare sector with a P/E of 28.59, slightly below the sector median of 31.9, but its price-to-sales ratio of 4.09 is above the sector median of 3.7. The company's profit margin and ROE significantly outperform sector averages.
What is Stryker Corp.'s stock forecast for 2030?
Based on Monte Carlo simulations, Stryker Corp.'s (SYK) stock forecast for 2030 includes a base case price of $380.51, a downside projection of $190.23, and an upside projection of $761.12. These are statistical outcomes, not guaranteed price targets.